Symbol | Exchange | Currency |
|---|
This move is a reversal from the hour prior, which saw price move up.The post Davita Inc (DVA): Price Now Near $125.57; Daily Chart Shows An Uptrend on 20 Day Basis appeared first...
RBC Capital analyst Frank Morgan maintained a Hold rating on DaVita (NYSE:DVA) on Friday, setting a price target of $108, which is approximately 7.32% below the present share price...
DaVita HealthCare Partners (DVA): Q1 GAAP EPS of $2.09 beats by $0.25.Revenue of $2.82B (-0.7% Y/Y) in-line.FY21 Guidance:Press Release
Merit Medical Systems (NASDAQ:MMSI), Inc. MMSI is gaining traction from portfolio expansion and solid prospects in its Peripheral Intervention unit.The company, with a market...
Developments on the COVID-19 vaccine last week helped buoy a variety of stocks. On Friday, the S&P 500 and Russell 2000 reached new all-time highs, while the NASDAQ closed...
Veeva Systems (NYSE:VEEV) Inc. VEEV announced the development of the company’s Veeva Clinical Network solution-based first two applications viz. Veeva Site Connect and Veeva...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Sell | Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Neutral | Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,278.38 | 2,284.72 | 2,250.00 | +49.34 | +2.21% | 1.60M | NASDAQ | |||
| 315.94 | 316.85 | 309.08 | +10.68 | +3.50% | 19.25M | NASDAQ | |||
| 130.15 | 131.42 | 127.81 | +3.04 | +2.39% | 9.39M | NASDAQ | |||
| 209.51 | 210.94 | 206.02 | +3.43 | +1.66% | 31.63M | NYSE | |||
| 1.58 | 1.61 | 1.4779 | +0.1100 | +7.48% | 298.62K | NASDAQ | |||
| 12.98 | 14.34 | 12.57 | +0.21 | +1.64% | 207.59M | NYSE | |||
| 10.50 | 11.79 | 10.14 | +0.55 | +5.53% | 39.98M | NYSE | |||
| 32.32 | 32.45 | 32.11 | +1.04 | +3.32% | 415.50K | OTC Markets | |||
| 159.92 | 166.47 | 156.22 | -4.58 | -2.78% | 4.29M | NYSE | |||
| 18.35 | 18.50 | 17.30 | +1.12 | +6.50% | 8.52M | NASDAQ | |||
| 20.08 | 20.20 | 18.53 | +1.71 | +9.31% | 79.41M | NYSE | |||
| 186.21 | 187.82 | 177.58 | +6.91 | +3.85% | 9.59M | NASDAQ | |||
| 25.70 | 25.99 | 23.87 | +2.14 | +9.08% | 14.86M | NYSE | |||
| 78.29 | 79.15 | 78.22 | -0.40 | -0.51% | 7.89M | NYSE | |||
| 58.69 | 59.26 | 58.67 | -0.12 | -0.20% | 13.77M | NYSE |
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.